Business registries · firm from USPTO records

Schering Corporation

Place
2000 Galloping Hill Road, Kenilworth, NJ
Entity type
Corporation
State of organization
NJ (as the owner states it in trademark filings)
Patents
214 granted 1915-10-21 to 2013-01-01
Trademarks
431, 154 live
Record
EXACT high confidence: identical full name and state
State business registration
SCHERING CORPORATION EXACT high confidence: identical full name and state
Source
USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place

Patents

PatentTitleGrantedSource
US 8343492Method for blocking binding of CX3C chemokines using CX3C chemokine antibodies2013-01-01PVGPATDIS, file of 2026-04-10
US 8293883Engineered anti-IL-23P19 antibodies2012-10-23PVGPATDIS, file of 2026-04-10
US 8273790Exo-selective synthesis of himbacine analogs2012-09-25PVGPATDIS, file of 2026-04-10
US 8263748Lyophilized formulations of engineered anti-IL-23p19 antibodies2012-09-11PVGPATDIS, file of 2026-04-10
US 8263070Methods of modulating CD200 receptors2012-09-11PVGPATDIS, file of 2026-04-10
US 8258319Exo- and diastereo- selective synthesis of himbacine analogs2012-09-04PVGPATDIS, file of 2026-04-10
US 8257921NRIP1 regulation of apolipoprotein A12012-09-04PVGPATDIS, file of 2026-04-10
US 8242112Heterocyclic aspartyl protease inhibitors2012-08-14PVGPATDIS, file of 2026-04-10
US 8236309Use of bispecific antibodies to regulate immune responses2012-08-07PVGPATDIS, file of 2026-04-10
US 8232372Engineered anti-TSLP antibody2012-07-31PVGPATDIS, file of 2026-04-10
US 82276052-aminothiazole-4-carboxylic amides as protein kinase inhibitors2012-07-24PVGPATDIS, file of 2026-04-10
US 8226947Interleukin-10 antibodies2012-07-24PVGPATDIS, file of 2026-04-10
US 82222591,2,4-triazolo[4,3-c]pyrimidin-3-one and pyrazolo[4,3-e]-1,2,4-triazolo[4,3-c]pyrimidin-3-one compounds for use as adenosine A2a receptor antagonists2012-07-17PVGPATDIS, file of 2026-04-10
US 8216571Fully human anti-VEGF antibodies and methods of using2012-07-10PVGPATDIS, file of 2026-04-10
US 8212016NPC1L1 orthologues2012-07-03PVGPATDIS, file of 2026-04-10
US 8212008Antibodies to CD200R2012-07-03PVGPATDIS, file of 2026-04-10
US 8211854Methods for inhibiting protein kinases2012-07-03PVGPATDIS, file of 2026-04-10
US 8207221Crystalline polymorphs of a CXC-chemokine receptor ligand2012-06-26PVGPATDIS, file of 2026-04-10
US 8207170Heterocyclic substituted piperazines with CXCR3 antagonist activity2012-06-26PVGPATDIS, file of 2026-04-10
US 8206943Assay for PCSK9 inhibitors2012-06-26PVGPATDIS, file of 2026-04-10
US 8202854Heterocyclic aspartyl protease inhibitors2012-06-19PVGPATDIS, file of 2026-04-10
US 8198463Process for the preparation of 6,6-dimethyl-3-azabicyclo-[3.3.0]-hexane compounds and enantiomeric salts thereof2012-06-12PVGPATDIS, file of 2026-04-10
US 8197812IL-1-like cytokine antibodies2012-06-12PVGPATDIS, file of 2026-04-10
US 8193319Antibodies to IL-17A2012-06-05PVGPATDIS, file of 2026-04-10
US 8187596Method of treating asthma or allergy by administering an IL-33 receptor antibody2012-05-29PVGPATDIS, file of 2026-04-10

The newest 25 of 214. All patents of this assignee

Trademarks

MarkSerialFiledStatusClassesSource
(design)855990722012-04-16Abandoned005TRCFECO2, file of 2024-03-27
MERCKMSD855921042012-04-09Registration cancelled044TRCFECO2, file of 2024-03-27
SELECTDOSE855425622012-02-14Abandoned005, 010TRCFECO2, file of 2024-03-27
SYMTWIST855355812012-02-07Abandoned005, 010TRCFECO2, file of 2024-03-27
CLARAMENTE CLARITIN855141582012-01-11Registration cancelled005TRCFECO2, file of 2024-03-27
CLEARCLICK854919252011-12-09Abandoned005TRCFECO2, file of 2024-03-27
REDITWIST854919222011-12-09Abandoned005TRCFECO2, file of 2024-03-27
SIMTWIST854919192011-12-09Abandoned005TRCFECO2, file of 2024-03-27
PRESCRIBEWELL854877832011-12-06Registration cancelled044TRCFECO2, file of 2024-03-27
PROVIDEWELL854877812011-12-06Registration cancelled044TRCFECO2, file of 2024-03-27
CLEARCLICK854850752011-12-01Abandoned005, 010TRCFECO2, file of 2024-03-27
SIMTWIST854850712011-12-01Abandoned005, 010TRCFECO2, file of 2024-03-27
REDITWIST854850702011-12-01Abandoned005, 010TRCFECO2, file of 2024-03-27
CALIBEROFCARE854767352011-11-18Abandoned041, 044TRCFECO2, file of 2024-03-27
VREE854551462011-10-25Registration cancelled009TRCFECO2, file of 2024-03-27
IMPROLI854246322011-09-16Abandoned005TRCFECO2, file of 2024-03-27
REVGASIL854130032011-09-01Registration cancelled005TRCFECO2, file of 2024-03-27
GARIXEDE854129362011-09-01Registration cancelled005TRCFECO2, file of 2024-03-27
STICK UP FOR YOURSELF853956042011-08-11Registration cancelled005TRCFECO2, file of 2024-03-27
LIDAPTRE853905752011-08-05Abandoned005TRCFECO2, file of 2024-03-27
MERCK853469852011-06-15Registered and renewed005, 044TRTYRAP, file of 2026-04-03
(design)853187892011-05-12Abandoned044TRCFECO2, file of 2024-03-27
(design)853187882011-05-12Abandoned044TRCFECO2, file of 2024-03-27
(design)853187872011-05-12Abandoned044TRCFECO2, file of 2024-03-27
(design)853187862011-05-12Abandoned044TRCFECO2, file of 2024-03-27

The newest 25 of 431. All marks of this owner

Sharing an address can mean a parent and subsidiary, a shared office or a registered agent; it isn’t proof of a connection.

Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.